Novan (NOVN) Says FDA Advised it That Additional Pivotal Trial Should be Conducted for SB204
Tweet Send to a Friend
Novan, Inc. ( (NASDAQ: NOVN) today announced that it has concluded a guidance meeting with the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
